Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.05.006
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Elsevier BV